

Endoglin Antibody (2Q1707) is a rat monoclonal IgG2a antibody that recognizes Endoglin in mouse, rat, and human samples through western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and flow cytometry (FCM). Anti-Endoglin antibody (2Q1707) targets a co-receptor for transforming growth factor-beta (TGF-β) superfamily ligands, which regulate endothelial cell proliferation, migration, and differentiation, playing a crucial role in vascular development and homeostasis. Endoglin (2Q1707) monoclonal antibody helps researchers understand hereditary hemorrhagic telangiectasia (HHT), a genetic disorder where mutations in Endoglin disrupt normal blood vessel formation, leading to hemorrhages and ischemia. Endoglin (2Q1707) antibody enables studies of vascular endothelial cells, supporting research in vascular biology, endothelial function, and vascular disorder pathogenesis.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Endoglin/CD105 Antibody (2Q1707) | sc-71042 | 200 µg/ml | $322.00 |